Although pre-COVID-19 analyses reported no significant difference in ACE2 levels according to age [17,18], ACE2 expression in the lungs of COVID-19-infected patients has been demonstrated to correlate with age [16,19], and disease severity also showed an association with ACE2 levels in the respiratory system [20,21]. This evidence concerns the gene ACE2 and COVID-19.